Press release
Global Bacterial and Viral Specimen Collection Market Expected to Grow at a Rapid Pace Due to the Rising Prevalence of Infectious Diseases and COVID-19 Pandemic.
Bacterial Viral Specimen Collection Market
The demand for such devices has also increased due to the growing adoption of point-of-care and home-based testing. The market growth is being driven by the development of innovative and advanced specimen collection devices that provide accurate and reliable results. However, the COVID-19 pandemic has caused supply chain disruptions, which could impede market growth. Governments worldwide are promoting early diagnosis and treatment of infectious diseases, and such initiatives are boosting the demand for bacterial and viral specimen collection devices. Despite these challenges, the market is expected to witness steady growth in the coming years.
Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/6258
Key players in the Bacterial and Viral Specimen Collection Market -
• Copan Italia S.p.A.
• Becton, Dickinson and Company
• QIAGEN
• Thermo Fisher Scientific Inc.
• Hardy Diagnostics
• Puritan Medical Products
• Meridian Bioscience, Inc.
• Lucence Diagnostics Pte Ltd
• Vircell S.L.
Segments Covered in the Report
The global bacterial and viral specimen collection market is segmented based on product type and specimen type. Based on product type, the market is segmented into swabs, kits and media, and viral transport media. Among these, the swabs segment holds a significant share in the market. The increasing demand for swabs can be attributed to the growing need for specimen collection devices in diagnostic laboratories and hospitals for testing various infectious diseases such as COVID-19. Furthermore, swabs are easy to use and do not require any special expertise, which is driving their adoption in home-based testing.
The kits and media segment is also expected to witness significant growth during the forecast period. This can be attributed to the increasing demand for diagnostic testing, particularly in the wake of the COVID-19 pandemic. The segment includes various types of kits and media, such as collection tubes, reagents, and buffers, which are used for the collection, transportation, and storage of samples.
Based on specimen type, the market is segmented into respiratory, urine, blood, and others. Among these, the respiratory segment holds a significant share in the market. This can be attributed to the high prevalence of respiratory infections, particularly in the wake of the COVID-19 pandemic. The segment includes various respiratory specimens such as nasopharyngeal swabs, throat swabs, and sputum, which are collected for diagnostic testing.
The urine segment is also expected to witness significant growth during the forecast period. This can be attributed to the increasing prevalence of urinary tract infections and the growing demand for urine-based diagnostic testing. Urine specimens are easy to collect and transport, and can be used for the detection of various infectious diseases and conditions such as diabetes and kidney diseases.
The blood segment is also witnessing significant growth, driven by the increasing demand for blood-based diagnostic testing for infectious diseases such as HIV, hepatitis, and malaria. Blood specimens can be collected through venipuncture or fingerstick, and can be used for the detection of various infectious diseases and conditions. Finally, the others segment includes various types of specimens such as stool, cerebrospinal fluid, and wound swabs, among others, which are collected for diagnostic testing.
Access Full Report Description with Research Methodology and Table of Contents @ https://www.reportsanddata.com/report-detail/bacterial-viral-specimen-collection-market
Strategic development:
Thermo Fisher Scientific Inc. strengthened its expertise in the biopharmaceutical production industry by acquiring Becton, Dickinson and Company's Advanced Bioprocessing business on October 25th, 2018. The acquisition allowed Thermo Fisher Scientific to improve its capabilities in downstream purification and cell culture media, enabling it to better serve the needs of its biopharmaceutical customers.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6258
Read More About: -
Bacterial Conjunctivitis Market - https://www.reportsanddata.com/report-detail/bacterial-conjunctivitis-market
Optometry Equipment Market - https://www.reportsanddata.com/report-detail/optometry-equipment-market
Metformin Hydrochloride Market - https://www.reportsanddata.com/report-detail/metformin-hydrochloride-market
Creatinine Test Market - https://www.reportsanddata.com/report-detail/creatinine-test-market
Naphazoline Hydrochloride, Chlorphenamine Maleate & Vitamin B12 Eye Drops Market - https://www.reportsanddata.com/report-detail/naphazoline-hydrochloride-chlorphenamine-maleate-and-vitamin-b12-eye-drops-market
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Bacterial and Viral Specimen Collection Market Expected to Grow at a Rapid Pace Due to the Rising Prevalence of Infectious Diseases and COVID-19 Pandemic. here
News-ID: 3040134 • Views: …
More Releases from reports and data
U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billio …
The U.S. Electric Vehicle (EV) Charging Infrastructure Market reached a value of USD 5.48 billion in 2024 and is projected to surge to USD 56.73 billion by 2034, fueled by a robust CAGR of 26.1% over the period. This unprecedented growth underscores the sector's central role in decarbonizing transportation and meeting the soaring demands of electric mobility.
Market Drivers
Federal & State Policies: Major initiatives, including the Bipartisan Infrastructure Law and significant…
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Dr …
The global Automotive Refurbished Turbochargers Market is set to grow from USD 0.9 billion in 2024 to USD 1.7 billion by 2034, recording a steady compound annual growth rate (CAGR) of 6.00%. This growth is being propelled by rising demand for affordable, fuel-efficient automotive solutions and stricter environmental regulations pushing the need for emission-reducing technologies.
Get Free Sample Report and Related Graphs & Charts @https://www.reportsanddata.com/sample-enquiry-form/19490
Passenger vehicles remain the largest segment of…
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Dr …
The global Automotive Powertrain Cooling System Market is projected to grow from USD 4.3 billion in 2024 to USD 8.2 billion by 2034, at a CAGR of 6.60%, according to the latest market study. This growth is fueled by the rising demand for fuel-efficient vehicles, increasing electric vehicle (EV) sales, and stricter global emission regulations.
Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.reportsanddata.com/sample-enquiry-form/19489
Electric and…
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
The global Automotive Inverter Market is on track for strong expansion, with forecasts projecting it will rise from USD 4.8 billion in 2024 to USD 16.9 billion by 2034, marking a compound annual growth rate (CAGR) of 13.2%. This rapid growth is being propelled by the increasing adoption of electric and hybrid vehicles, along with continued innovation in inverter technologies.
Electric vehicles (EVs) are the main driver behind this surge, as…
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
